Low exogenous lactate clearance as an early predictor of mortality in normolactatemic critically ill septic patients

Critical Care Medicine

Volumn 31, Issue 3, 2003, Pages 705-710

  Levraut, Jacques ^a   Ichai, Carole ^a   Petit, Isabelle ^a   Ciebiera, Jean Pierre ^a   Perus, Olivier ^a   Grimaud, Dominique ^a  

^a University Hospital of Nice University of Nice Sophia Antipolis   (France)

Author keywords

Critical care; Hypoxia; Inflammation; Lactate; Metabolism; Multiple organ failure; Prognosis; Sepsis; Septic shock; Stress

Indexed keywords

LACTIC ACID;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CALCULATION; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG CLEARANCE; EARLY DIAGNOSIS; EVALUATION; FEMALE; HUMAN; INTENSIVE CARE; LACTATE BLOOD LEVEL; LACTATE CLEARANCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; OBSERVATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SEPSIS; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME;

AGE DISTRIBUTION; AGE FACTORS; AGED; BLOOD GAS ANALYSIS; COMORBIDITY; CRITICAL ILLNESS; FEMALE; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; LACTIC ACID; LOGISTIC MODELS; MALE; METABOLIC CLEARANCE RATE; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTHROMBIN TIME; RISK FACTORS; ROC CURVE; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0037351946     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000045561.85810.45     Document Type: Article

References (49)

1. Weil MH, Afifi A: Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure. Circulation 1970; 41:989-1001
2. Mizock BA, Falk JL: Lactic acidosis in critical illness. Crit Care Med 1992; 20:80-93
3. Bernardin G, Pradier C, Tiger F, et al: Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med 1996; 22:17-25
4. Levy B, Sadoune LO, Gdot AM, et al: Evolution of lactate/pyruvate and ketone body ratios in the early course of catecholamine- treated septic shock. Crit Care Med 2000; 28:114-119
5. Gutierrez G, Wulf ME: Lactic acidosis in sepsis: A commentary. Intensive Care Med 1996; 22:6-16
6. James JH, Luchette FA, McCarter FD, et al: Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999; 354:505-508
7. Hotchkiss RS, Karl IE: Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. JAMA 1992; 276:1503-1510
8. O'Brien WJ, Lingrd JB, Fischer JE, et al: Sepsis increases skeletal muscle sodium, potassium-adenosinetriphosphatase activity without affecting messenger RNA or protein levels. J Am Coll Surg 1996; 183:471-479
9. Mizock BA: Metabolic derangements in sepsis and septic shock. Crit Care Clin 2000; 16:319-336
10. Levraut J, Ciebiera JP, Chave S, et al: Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 1998; 157:1021-1026
11. Gladden LB: Muscle as a consumer of lactate. Med Sci Sports Exerc 2000; 32:764-771
12. Van Hall G: Lactate as a fuel for mitochondrial respiration. Acta Physiol Scand 2000; 168:643-646
13. Joynt GM, Lipman J, Gomersall CD, et al: Gastric intramucosal pH and blood lactate in severe sepsis. Anaesthesia 1997; 52:726-732
14. Bakker J, Gris P, Coffernils M, et al: Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg 1996; 171:221-226
15. Friedman G, Berlot G, Kahn RJ, et al: Combined measurements of blood lactate concentrations and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995; 23:1184-1193
16. Vallet B, Chopin C, Curtis SE, et al: Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: A prospective, multicenter study. Crit Care Med 1993; 21:1868-1875
17. Rhodes A, Lamb FJ, Malagon I, et al: A prospective study of the use of a dobutamine stress to identify outcome in patients with sepsis, severe sepsis or septic shock. Crit Care Med 1999; 27:2361-2366
18. De Backer D, Creteur J, Silva E, et al: The hepatosplanchnic area is not a common source of lactate in patients with severe sepsis. Crit Care Med 2001; 29:256-261
19. Oud L, Haupt MT: Persistent gastric intramucosal ischemia in patients with sepsis following resuscitation from shock. Chest 1999; 115:1390-1396
20. +-lactate metabolism in normal man. Ann Nutr Metab 1982; 26:254-263
21. Iliadis A, Brown AC, Huggins ML: Apis: A software for model identification, simulation and dosage regimen calculations in clinical and experimental pharmacokinetics. Comput Methods Program Biomed 1992; 38:227-239
22. Sheiner LB, Beal S, Rosenberg B, et al: Forecasting individual pharmacokinetics. Clin Pharmacol Ther 1979; 26:294-305
23. Use of catecholamines in septic shock (adults, children). Fifteenth Consensus Conference on Intensive Care and Emergency Medicine, Lille, France, June 13, 1996. Ann Fr Anesth Reanim 1997; 16:205-209
24. Choice of vascular filling products for the treatment of hypovolemia in adults. Fourth Consensus Conference on Intensive Care and Emergency Medicine. Nantes, France, May 19, 1989. Rev Prat 1990; 11:747-749
25. Fagon JY, Chastre J, Novara A, et al: Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctions and/or infection: The ODIN model. Intensive Care Med 1993; 19: 137-144
26. Greenland S: Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79:340-349
27. Kleimbaum DG: Logistic Regression. New York, NY, Springer-Verlag, 1994, pp 282
28. Smith I, Kumar P, Molloy S, et al: Base excess and lactate as prognostic indicators for patients admitted to intensive care. Intensive Care Med 2001; 27:74-83
29. Capuzzo M, Valpondi V, Sgarbi A, et al: Validation of severity scoring systems SAPS II and APACHE II in a single-center population. Intensive Care Med 2000; 26:1779-1785
30. Le Gall JR, Lemeshow S, Leleu G, et al: Customized probability models for early severe sepsis in adult intensive care patients. Intensive Unit Scoring Group. JAMA 1995; 273:644-650
31. Oda S, Hirasawa H, Sugai T, et al: Comparison of sepsis-related organ failure assessment (SOFA) score and CIS (cellular injury score) for scoring of severity for patients with multiple organ dysfunction syndrome (MODS). Intensive Care Med 2000; 26:1786-1793
32. Madias NE: Lactic acidosis. Kidney Int 1986; 29:752-774
33. Woll PJ, Record CO: Lactate elimination in man: Effects of lactate concentration and hepatic dysfunction. Eur J Clin Invest 1979; 9:397-404
34. +-lactate in patients with liver disease. Ann Nutr Metab 1982; 26:308-314
35. Vettor R, Lombardi AM, Fabris R, et al: Lactate infusion in anesthetized rats produces insulin resistance in heart and skeletal muscle. Metabolism 1997; 46:684-690
36. Gutierrez G, Hurtado FJ, Gutierrez AM, et al: Net uptake of lactate by rabbit hindlimb during hypoxia. Am Rev Respir Dis 1993; 148: 1204-1209
37. Schurr A, Payne RS, Hiller JJ, et al: Blockade of lactate transport exacerbates delayed neuronal damage in a rat model of cerebral ischemia. Brain Res 2001; 895:268-272
38. Vary TC, Siegel JH, Nakatani T, et al: Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 1986; 250:E634-E640
39. Vary TC, Hazen SA: Sepsis alters pyruvate dehydrogenase kinase activity in skeletal muscle. Mol Cell Biochem 1999; 198: 113-118
40. Vary T: Sepsis-induced alterations in pyruvate dehydrogenase complex activity in rat skeletal muscle: Effects on plasma lactate. Shock 1996; 6:89-94
41. Vary TC, Hazen SA, Maish G, et al: TNF binding protein prevents hyperlactatemia band inactivation of PDH complex in skeletal muscle during sepsis. J Surg Res 1998; 80:44-51
42. Gore DC, Jahoor F, Hibbert JM, et al: Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg 1996; 224:97-102
43. Crouser ED, Julian MW, Blaho DV, et al: Endotoxin-induced mitochondrial damage correlates with impaired respiratory activity. Crit Care Med 2002; 30:276-284
44. Mizock BA: The hepatosplanchnic area and hyperlactatemia: A tale of two lactates. Crit Care Med 2001; 29:447-449
45. Hurtado FJ, Gutierrez AM, Silva N, et al: Role of tissue hypoxia as the mechanism of lactic acidosis during E. coli endotoxemia. J Appl Physiol 1992; 72:1895-1901
46. Boekstegers P, Weidenhofer S, Pilz G, et al: Peripheral oxygen availability within skeletal muscle in sepsis and septic shock: Comparison to limited infection and cardiogenic shock. Infection 1991; 19:317-323
47. James JH, Fang CH, Schrantz SJ, et al: Linkage of aerobic glycolysis to sodium-potassium transport in rat skeletal muscle: Implications for increased muscle lactate production in sepsis. J Clin Invest 1996; 98: 2388-2397
48. Haji-Michael PG, Ladriere L, Sener A, et al: Leukocyte glycolysis and lactate output in animal sepsis and ex vivo human blood. Metabolism 1999; 48:779-785
49. Meszaros K, Lang CH, Bagby GJ, et al: Contribution of different organs to increased glucose consumption after endotoxin administration. J Biol Chem 1987; 262:10965-10970